Business Description
ImmunoPrecise Antibodies Ltd
NAICS : 325412
SIC : 3741
ISIN : CA45257F1018
Description
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | -0.59 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -2.9 | |||||
| Beneish M-Score | -3.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7 | |||||
| 3-Year EBITDA Growth Rate | -111.7 | |||||
| 3-Year EPS without NRI Growth Rate | -5.6 | |||||
| 3-Year FCF Growth Rate | -18 | |||||
| 3-Year Book Growth Rate | -27.1 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 22.52 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.09 | |||||
| 9-Day RSI | 33.79 | |||||
| 14-Day RSI | 37.96 | |||||
| 6-1 Month Momentum % | -60.53 | |||||
| 12-1 Month Momentum % | -67.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.41 | |||||
| Quick Ratio | 1.15 | |||||
| Cash Ratio | 0.43 | |||||
| Days Inventory | 66.79 | |||||
| Days Sales Outstanding | 51.42 | |||||
| Days Payable | 118.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12 | |||||
| Shareholder Yield % | -26.36 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.17 | |||||
| Operating Margin % | -56.2 | |||||
| Net Margin % | -110.18 | |||||
| FCF Margin % | -22.94 | |||||
| ROE % | -54.49 | |||||
| ROA % | -36.59 | |||||
| ROIC % | -20.59 | |||||
| 3-Year ROIIC % | -26.62 | |||||
| ROC (Joel Greenblatt) % | -185.43 | |||||
| ROCE % | -42.94 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.9 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 9.92 | |||||
| EV-to-EBIT | -1.18 | |||||
| EV-to-EBITDA | -1.48 | |||||
| EV-to-Revenue | 1.38 | |||||
| EV-to-Forward-Revenue | 1.14 | |||||
| EV-to-FCF | -6.02 | |||||
| Earnings Yield (Greenblatt) % | -84.75 | |||||
| FCF Yield % | -23.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ImmunoPrecise Antibodies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 16.796 | ||
| EPS (TTM) (€) | -0.717 | ||
| Beta | 0.12 | ||
| Volatility % | 38.92 | ||
| 14-Day RSI | 37.96 | ||
| 14-Day ATR (€) | 0.03851 | ||
| 20-Day SMA (€) | 0.62555 | ||
| 12-1 Month Momentum % | -67.39 | ||
| 52-Week Range (€) | 0.464 - 2.36 | ||
| Shares Outstanding (Mil) | 27.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ImmunoPrecise Antibodies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ImmunoPrecise Antibodies Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
ImmunoPrecise Antibodies Ltd Frequently Asked Questions
What is ImmunoPrecise Antibodies Ltd(FRA:TQB)'s stock price today?
The current price of FRA:TQB is €0.50. The 52 week high of FRA:TQB is €2.36 and 52 week low is €0.46.
When is next earnings date of ImmunoPrecise Antibodies Ltd(FRA:TQB)?
The next earnings date of ImmunoPrecise Antibodies Ltd(FRA:TQB) is 2024-09-16.
Does ImmunoPrecise Antibodies Ltd(FRA:TQB) pay dividends? If so, how much?
ImmunoPrecise Antibodies Ltd(FRA:TQB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers